Terms: = Liver cancer AND BRIP1, MGC126521, 83990, ENSG00000136492, FANCJ, FLJ90232, Q9BX63, MGC126523, OF AND Treatment
544 results:
1. Undifferentiated Embryonal Sarcoma of the liver with Epithelioid Features: A Case Report of an Exceptional Histological Heterogeneity among Rare Diseases.
Kersik A; Bracchetti G; Bonomi A; Bovo G; Serena Cuttin M; Germini A; Gjoni E; Granieri S; Cotsoglou C
Ann Ital Chir; 2024; 95(2):119-125. PubMed ID: 38684493
[TBL] [Abstract] [Full Text] [Related]
2. Uncommon using of the pulmonary homograft in oncological case - three years follow up.
Lahidheb D; Komarov R; Alikhanov R; Tlisov B; Ismailbaev A; Dhif I
J Cardiothorac Surg; 2024 Apr; 19(1):204. PubMed ID: 38615010
[TBL] [Abstract] [Full Text] [Related]
3. Special populations in metastatic renal cell carcinoma.
Goodstein T; Goldberg I; Acikgoz Y; Hasanov E; Srinivasan R; Singer EA
Curr Opin Oncol; 2024 May; 36(3):186-194. PubMed ID: 38573208
[TBL] [Abstract] [Full Text] [Related]
4. Esculin induces endoplasmic reticulum stress and drives apoptosis and ferroptosis in colorectal cancer via PERK regulating eIF2α/CHOP and Nrf2/HO-1 cascades.
Ji X; Chen Z; Lin W; Wu Q; Wu Y; Hong Y; Tong H; Wang C; Zhang Y
J Ethnopharmacol; 2024 Jun; 328():118139. PubMed ID: 38561058
[TBL] [Abstract] [Full Text] [Related]
5. Adjuvant treatment with Cordyceps sinensis for lung cancer: A systematic review and meta-analysis of randomized controlled trials.
Wang C; Wang J; Qi Y
J Ethnopharmacol; 2024 Jun; 327():118044. PubMed ID: 38484953
[TBL] [Abstract] [Full Text] [Related]
6. Expanding MELD exceptions for colorectal liver metastasis: data and policy.
Whitrock JN; Pratt CG; Shah SA
Curr Opin Organ Transplant; 2024 Jun; 29(3):195-199. PubMed ID: 38483122
[TBL] [Abstract] [Full Text] [Related]
7. A nanomedicine composed of polymer-ss-DOX and polymer-Ce6 prodrugs with monoclonal antibody targeting effect for anti-tumor chemo-photodynamic synergetic therapy.
Yu L; Zhang M; He J; Sun X; Ni P
Acta Biomater; 2024 Apr; 179():272-283. PubMed ID: 38460931
[TBL] [Abstract] [Full Text] [Related]
8. Progress in clinical and basic research of fuzheng Huayu formula for the treatment of liver fibrosis.
Zhou X; Fu Y; Chen J; Liu P
J Ethnopharmacol; 2024 Jun; 327():118018. PubMed ID: 38453100
[TBL] [Abstract] [Full Text] [Related]
9. Therapeutic potential of traditional Chinese medicine in the prevention and treatment of digestive inflammatory cancer transformation: Portulaca oleracea L. as a promising drug.
Shao G; Liu Y; Lu L; Wang L; Ji G; Xu H
J Ethnopharmacol; 2024 Jun; 327():117999. PubMed ID: 38447616
[TBL] [Abstract] [Full Text] [Related]
10. The mechanism and experimental verification of Ixeris sonchifolia promoting apoptosis of hepatocellular carcinoma based on network pharmacology: Ixeris sonchifolia Induces Hepatocellular Carcinoma Apoptosis via the PI3K/AKT Pathway.
Liu BJ; Guan YY; Qiao LX; Zhang JM; Li AJ; Yang PX; Gao YX; Chen DX; Wang CX; Wu J
J Ethnopharmacol; 2024 Jun; 327():117994. PubMed ID: 38437889
[TBL] [Abstract] [Full Text] [Related]
11. Investigating the molecular mechanism of Qizhu anticancer prescription in inhibiting hepatocellular carcinoma based on high-resolution mass spectrometry and network pharmacology.
Sun J; Ma M; Zhong X; Li J; Yi J; Zhang R; Liu X; Peng L; Sun X; Feng W; Hu R; Huang Q; Lv M; Fan K; Zhou X
J Ethnopharmacol; 2024 Jun; 328():117985. PubMed ID: 38417600
[TBL] [Abstract] [Full Text] [Related]
12. Transarterial Chemoembolization with Epirubicin-Loaded Microspheres for Hepatocellular Carcinoma: A Prospective, Single-Arm, Multicenter, Phase 2 Study (STOPPER Trial).
Zhu HD; Li X; Sun JH; Zhu X; Liu ZY; Li HL; Lu J; Yan ZP; Shao GL; He XF; Chao M; Lu LG; Zhong BY; Li R; Zhang Q; Teng GJ
Cardiovasc Intervent Radiol; 2024 Mar; 47(3):325-336. PubMed ID: 38413420
[TBL] [Abstract] [Full Text] [Related]
13. Indigenous wisdom of a Kwatha to treat NASH: An insight into the mechanism.
Yellurkar ML; Prasanna VS; Das P; Sarkar S; Matta R; Dhaked DK; Peraman R; Taraphdar AK; Nanjappan SK; Velayutham R; Arumugam S
J Ethnopharmacol; 2024 May; 326():117935. PubMed ID: 38408692
[TBL] [Abstract] [Full Text] [Related]
14. Diagnosis and management of immune mediated liver injury from checkpoint inhibitors.
Likhitsup A; Fontana RJ
Curr Opin Gastroenterol; 2024 May; 40(3):164-171. PubMed ID: 38375823
[TBL] [Abstract] [Full Text] [Related]
15. Identification of Erzhu Jiedu Recipe and its molecular mechanism underlying inhibited human hepatoma cells by UHPLC-Q-Exactive Orbitrap HRMS and network pharmacology.
Wang F; Mai J; Wang H; Xu Y; Zhou X; Xie Z; Yu B; Liu P; Liu W; Cheng Y
J Ethnopharmacol; 2024 May; 325():117893. PubMed ID: 38336184
[TBL] [Abstract] [Full Text] [Related]
16. Factors Impacting Survival After Transarterial Radioembolization in Patients with Unresectable Intrahepatic Cholangiocarcinoma: A Combined Analysis of the Prospective CIRT Studies.
Reimer P; Vilgrain V; Arnold D; Balli T; Golfieri R; Loffroy R; Mosconi C; Ronot M; Sengel C; Schaefer N; Maleux G; Munneke G; Peynircioglu B; Sangro B; Kaufmann N; Urdaniz M; Pereira H; de Jong N; Helmberger T
Cardiovasc Intervent Radiol; 2024 Mar; 47(3):310-324. PubMed ID: 38321223
[TBL] [Abstract] [Full Text] [Related]
17. Anti-hepatocellular carcinoma activity of Sorbaria sorbifolia by regulating VEGFR and c-Met/apoptotic pathway.
Xu ZH; Dang Y; Dong Y; Dong CY; Liu Y; Chen X; Yao Z; Shi JP
J Ethnopharmacol; 2024 Apr; 324():117758. PubMed ID: 38246481
[TBL] [Abstract] [Full Text] [Related]
18. Cirrhotic hepatocellular carcinoma-based decellularized liver cancer model for local chemoembolization evaluation.
Wang M; Gao Y; Liu X; Li Z; Xiao J; Gao X; Gibson MI; Guo Q
Acta Biomater; 2024 Mar; 176():144-155. PubMed ID: 38244660
[TBL] [Abstract] [Full Text] [Related]
19. Comparison of Contrast-enhanced Ultrasound and Contrast-enhanced Magnetic Resonance Imaging in the Assessment of Infant Hip Perfusion and Prediction of Proximal Femoral Growth Disturbance Following Closed and Open Reduction for Developmental Dysplasia of the Hip: A Preliminary Study.
Matheney T; Shore B; Miller P; Barnewolt C; Kim YJ; Paltiel H
J Pediatr Orthop; 2024 Apr; 44(4):e335-e343. PubMed ID: 38193395
[TBL] [Abstract] [Full Text] [Related]
20. Oleander attenuates hepatic inflammation in a TLR4-independent manner and by favorable modulation of hepatocellular global metabolome that supports cytoprotection.
Dey P; Tewari N; Dutta S; Newman RA; Chaudhuri TK
J Ethnopharmacol; 2024 Apr; 323():117717. PubMed ID: 38181937
[TBL] [Abstract] [Full Text] [Related]
[Next]
